Jefferies Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

September 29, 2026 6:37 AM

Jefferies analyst Faisal Khurshid reiterated a Buy rating and $35.00 price target on Syndax Pharmaceuticals (NASDAQ: SNDX).The analyst comments "SNDX ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found